{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 449584568
| IUPAC_name = 1-(Benzo[1,3]dioxol-5-ylmethyl)piperazine
| image = MDBZP.svg
| width = 160
| image2 = MDBZP3d.png

<!--Clinical data-->
| tradename =
| routes_of_administration =

<!--Pharmacokinetic data-->
| metabolism =
| elimination_half-life =
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 32231-06-4
| ATC_prefix = none
| ATC_suffix =
| PubChem = 94426
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID      = 85214

<!--Chemical data-->
| C=12 | H=16 | N=2 | O=2
| molecular_weight = 220.268 g/mol
| smiles            = c1cc2c(cc1CN3CCNCC3)OCO2
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI          = 1S/C12H16N2O2/c1-2-11-12(16-9-15-11)7-10(1)8-14-5-3-13-4-6-14/h1-2,7,13H,3-6,8-9H2
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey       = NBOOZXVYXHATOW-UHFFFAOYSA-N
}}

'''1-(3,4-Methylenedioxybenzyl)piperazine''' ('''MDBZP''', '''piperonylpiperazine''') is a [[chemical compound]] of the [[piperazine]] [[chemical class]] related to [[benzylpiperazine]] (BZP).  MDBZP has been sold as a [[designer drug]]<ref>{{cite journal | author = Maurer, H.H., Kraemer, T., Springer, D. and Staack, R.F. | date = 2004 | title = Chemistry, pharmacology, toxicology, and hepatic metabolism of designer drugs of the amphetamine (ecstasy), piperazine, and pyrrolidinophenone types: a synopsis | journal = Ther. Drug Monitor. | volume = 26 | issue = 2 | pages = 127â€“131}}</ref> and has even been found as an ingredient in street [[Ecstasy (drug)|Ecstasy]] pills.{{cn|date=January 2016}}

== Chemical derivatives ==
* [[Piribedil]], an antiparkinsonian agent
* [[Medibazine]], a coronary vasodilator and bronchodilator
*[[Fipexide]]
*[[Fenoverine]]
*[[Pifarnine]]
*[[Peralopride]]

== See also ==
* [[MDMA|3,4-Methylenedioxy-''N''-methylamphetamine]] (MDMA)
* [[Substituted piperazine]]

== References ==
{{Reflist}}

==External links==
* {{cite document | url = http://www.who.int/medicines/areas/quality_safety/5.3eMDBZPpre-review.pdf | title =1-(3-4-methylendioxybenzyl)piperazine (MDBZP) Pre-Review Report | author = Expert Committee on Drug Dependence | date = 8 June 2012 | publisher = World Health Organization}}

{{Stimulants}}
{{Monoamine releasing agents}}
{{Piperazines}}

[[Category:Benzodioxoles]]
[[Category:Designer drugs]]
[[Category:Piperazines]]


{{nervous-system-drug-stub}}